Tag archive for ‘North Carolina’
Pepsi Bottling Ventures acquires Pepsi-Cola Roxboro
By businessnewstoday On Saturday, March 27th, 2021
0 Comments

Pepsi Bottling Ventures acquires Pepsi-Cola Roxboro

(adsbygoogle = window.adsbygoogle || []).push({}); Pepsi Bottling Ventures (PBV) has closed its acquisition of Pepsi-Cola Roxboro, a franchise bottler based in Roxboro, North Carolina for an undisclosed More...

Fujifilm cell culture manufacturing facility to come up in Holly Springs, North Carolina
By businessnewstoday On Friday, March 19th, 2021
0 Comments

Fujifilm cell culture manufacturing facility to come up in Holly Springs, NC

Fujifilm has selected Holly Springs of North Carolina as the location for its new $2 billion cell culture manufacturing facility in the US. In January 2021, the Japanese conglomerate announced setting up such a More...

ICON plc to acquire CRO PRA Health Sciences for $12bn
By businessnewstoday On Wednesday, February 24th, 2021
0 Comments

ICON plc to acquire CRO PRA Health Sciences for $12bn

ICON plc, an Ireland-based contract research organization (CRO), has agreed to acquire PRA Health Sciences in a cash-cum-stock deal worth around $12 billion. PRA Health Sciences is a US-based contract research organization. More...

World Insurance Associates to acquire Charlotte-based LCL Insurance
By businessnewstoday On Sunday, February 21st, 2021
0 Comments

World Insurance Associates to acquire Charlotte-based LCL Insurance

World Insurance Associates (WIA), a US insurance brokerage, has acquired LCL Insurance based in Charlotte, North Carolina, for an undisclosed price. LCL Insurance is engaged in providing risk management, risk placement, More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Wednesday, February 17th, 2021
0 Comments

Human tissue developer Humacyte to go public via $1.1bn merger with Alpha Healthcare

Humacyte, a clinical-stage biotech platform company, has agreed to merge with blank check company Alpha Healthcare Acquisition Corp. (AHAC), in a deal that values the combined firm at $1.1 billion. Based in Durham, More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Wednesday, February 17th, 2021
0 Comments

Human tissue developer Humacyte to go public via $1.1bn merger with Alpha Healthcare

Humacyte, a clinical-stage biotech platform company, has agreed to merge with blank check company Alpha Healthcare Acquisition Corp. (AHAC), in a deal that values the combined firm at $1.1 billion. Based in Durham, More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By businessnewstoday On Wednesday, January 27th, 2021
0 Comments

Surrey Bank & Trust to sell SB&T Insurance to Mountcastle Insurance

North Carolina-based Surrey Bank & Trust has agreed to divest SB&T Insurance, its fully-owned subsidiary, to Mountcastle Insurance for an undisclosed price. SB&T Insurance is an independent insurance More...

Safehold Special Risk acquires motorsports insurance firm WSIB Insurance
By businessnewstoday On Tuesday, January 12th, 2021
0 Comments

Safehold Special Risk acquires motorsports insurance firm WSIB Insurance

Safehold Special Risk, a program administrator that offers access to tailored insurance solutions for niche businesses and industries across the US, has acquired WSIB Insurance Agency. The financial terms of the More...

By pharmanewsdaily On Monday, October 26th, 2020
0 Comments

Bayer to acquire US gene therapy company Asklepios BioPharmaceutical in $4bn deal

German pharma giant Bayer has agreed to acquire US clinical-stage gene therapy company Asklepios BioPharmaceutical in a deal worth up to $4 billion. The portfolio of Asklepios BioPharmaceutical features investigational More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Monday, October 26th, 2020
0 Comments

Bayer to acquire US gene therapy company Asklepios BioPharmaceutical in $4bn deal

German pharma giant Bayer has agreed to acquire US clinical-stage gene therapy company Asklepios BioPharmaceutical in a deal worth up to $4 billion. The portfolio of Asklepios BioPharmaceutical features investigational More...